METTL14 rs428409: Understanding Your Genetic Variant
The rs428409 variant is a single-nucleotide polymorphism located within the METTL14 gene. Recent research suggests that specific genotypes of this variant may be associated with an altered risk of breast cancer in certain populations.
What each genotype means
Baseline risk profile
This genotype represents the common baseline state for this variant in the METTL14 gene. Research suggests that individuals with this genotype do not carry the specific allele associated with the elevated breast cancer risk observed in some studies. This finding is based on limited evidence and should be viewed as a statistical observation rather than a medical diagnosis.
This is the most common genotype in many global populations, though exact frequencies vary significantly by ancestry.
Potentially elevated risk
Carrying one copy of the C allele has been associated with an increased risk of breast cancer in some research studies. This association is based on statistical observations in specific populations and does not mean that an individual will develop the condition. You should discuss your overall health and family history with a healthcare provider to understand your personal risk factors.
This genotype is found at varying frequencies across different ethnic groups, with higher prevalence noted in some Asian populations.
Potentially elevated risk
Carrying two copies of the C allele is associated with an elevated risk of breast cancer in certain studies. This statistical association is based on population-level data and does not serve as a diagnostic tool for individual health outcomes. It is recommended to maintain routine health screenings and discuss your genetic findings with a medical professional.
This genotype is less common than the TT or TC genotypes in many populations, with frequency distributions that are highly dependent on ancestral background.
What is rs428409?
The rs428409 variant is a specific genetic change, or single-nucleotide polymorphism (SNP), found within the METTL14 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This particular variant involves a substitution where the nucleotide base thymine (T) can be replaced by cytosine (C). Because this change occurs in the DNA sequence, it can potentially influence how the body reads or processes the instructions encoded by the METTL14 gene. Scientists study these variations to understand how they might contribute to differences in health outcomes or disease susceptibility between individuals. It is important to note that having a specific genotype for this SNP does not mean an individual will develop a condition; rather, it is one of many factors that researchers investigate when looking at complex health traits.
The Role of the METTL14 Gene
The METTL14 gene provides instructions for creating a protein that is a key component of a methyltransferase complex. This complex is responsible for a process called N6-methyladenosine (m6A) modification, which is a common chemical change that occurs on messenger RNA (mRNA). By adding these chemical tags, the METTL14 protein helps regulate how mRNA is spliced, stabilized, and translated into functional proteins. Essentially, METTL14 acts as a structural scaffold that allows the complex to recognize and modify its target RNA molecules efficiently. Because this process is fundamental to gene expression and cellular function, researchers are highly interested in how variations in the METTL14 gene might disrupt these regulatory pathways. Dysregulation of m6A modification has been implicated in various biological processes, including cell growth, differentiation, and, in some contexts, the development of cancer.
Research and Evidence
Evidence regarding rs428409 is currently considered moderate and is primarily derived from case-control studies. A recent study published in 2025 investigated the relationship between several SNPs in the METTL3/14/16 genes and breast cancer susceptibility in a cohort of 680 patients and 680 healthy controls. The researchers observed that individuals carrying the TC or CC genotypes of rs428409 showed an elevated risk of breast cancer compared to those with the TT genotype. Furthermore, the study noted potential interactions between these genetic variants and various reproductive factors. While these findings are significant, they are specific to the population studied and require further validation in larger, more diverse cohorts to determine if the association holds true across different ancestries. As with many genetic associations, the evidence is not definitive, and the biological mechanisms linking this specific SNP to cancer risk are still being explored by the scientific community.
Understanding Your Information
Genetic information regarding variants like rs428409 should be interpreted with caution. It is essential to understand that a statistical association found in a research study does not constitute a medical diagnosis or a prediction of future health. Many factors, including environment, lifestyle, and the cumulative effect of thousands of other genetic variants, contribute to complex health outcomes like breast cancer. If you have concerns about your health or family history, the most appropriate step is to consult with a healthcare professional or a genetic counselor. They can help you contextualize your genetic information within the broader scope of your personal health history. Never use information from genetic databases to make medical decisions or change your health habits without professional guidance. Genetic research is an evolving field, and current findings are intended to advance scientific understanding rather than provide individual medical advice.
How common is this variant?
The frequency of the rs428409 variant is variable and depends significantly on ancestral background, with current research highlighting specific observations in Chinese populations.
Frequently asked questions
Does having the CC genotype mean I will get breast cancer?
No. A genetic association indicates a statistical trend observed in a study population, not a certainty for an individual. Many factors contribute to cancer risk, and this variant is only one small piece of a very complex puzzle.
Where can I find more information about METTL14?
You can explore resources like GeneCards or the National Center for Biotechnology Information (NCBI) Gene database. These platforms provide comprehensive summaries of gene functions and their roles in human biology.
Should I get tested for this variant?
Genetic testing for specific SNPs is generally not recommended for the general public unless advised by a doctor based on a strong family history or specific clinical concerns. Always discuss the necessity of any genetic testing with a qualified healthcare provider.
Is the evidence for rs428409 strong?
The evidence is currently considered moderate. While studies have shown an association, these findings often need to be replicated in larger, more diverse groups to confirm the strength and consistency of the link across different populations.
Sources & further reading
Educational information only, last refreshed 9/18/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs428409?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29